Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038700 | SCV000062378 | benign | not specified | 2018-03-14 | criteria provided, single submitter | clinical testing | c.259-8dup in intron 3 of NEBL: This variant is classified as benign because it has been identified in 23% (4831/20832) of African chromosomes by the Genome Agg regation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs753190853). ACMG/AMP Criteria: BA1. |
Gene |
RCV000038700 | SCV000236079 | benign | not specified | 2017-10-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000205140 | SCV000262102 | benign | Primary dilated cardiomyopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000038700 | SCV003928280 | benign | not specified | 2023-04-17 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000038700 | SCV001978185 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000038700 | SCV001980110 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003974889 | SCV004797871 | benign | NEBL-related disorder | 2019-05-20 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |